Reaction

Portopulmonary Hypertension reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 89 reports · 2 co-occurring drugs

As of the last recalculation, Portopulmonary Hypertension appears in 89 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 201.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Epoprostenol10201.1201.3
Sofosbuvir790.090.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.